Antiviral Treatments: Special Discount to Pharmacies and Health Stores Announced by Lilac Corp
Gene-Eden-VIR and Novirin are indexed on Pubmed as safe and effective natural treatments against viral infection. In light of the global interest in viruses, Lilac Corp is offering a special discount to pharmacies, health stores, retailers, and health practitioners interested in offering the treatments to their customers.
SARASOTA, Fla., Feb. 18, 2020 /PRNewswire/ -- The public is scared of viruses more than ever [1]. As a result, people are turning to their pharmacist and healthcare providers with questions about antiviral treatments. To address the growing need for treatments that target viruses, Lilac Corp. is announcing a new program aiming to increase the availability of Gene-Eden-VIR and Novirin, its antiviral treatments, through pharmacies, health stores, clinics, and other retailers.
Gene-Eden-VIR and Novirin were tested in clinical trials, and were found to be effective against several viruses. The tests also showed that Gene-Eden-VIR and Novirin are better than the standard antiviral drugs currently prescribed by doctors. The clinical trials were carried out according to FDA guidelines. The results were published in several peer reviewed medical journals, see for instance references [2] - [6].
Gene-Eden-VIR and Novirin are prescribed by doctors, and are indexed on Pubmed, which is the most selective and prestigious database of medical information in the world. Pubmed is managed by the US National Institute of Health (NIH).
Lilac Corp seeks to expand the availability of the two antiviral treatments to the general public, and therefore seeks to add new channels of distribution. Currently the two treatments are available online through the Lilac Corp website at lilaccorp.com. The treatments are also available in a selective number of pharmacies and clinics. We invite other pharmacies, retailers, naturalist stores, clinics, and retailers interested in carrying the treatments to contact Lilac Corp.
About Lilac Corp:
Lilac Corp's mission is to develop natural treatments against targets identified in the ground breaking model of human disease first described in the book: "Microcompetition with Foreign DNA and the Origin of Chronic Disease", ISBN 0-9740463-0-2.
For more information contact:
Lilac Corp. www.lilaccorp.com
[email protected]
941-227-7780
Elisheva Timber, Marketing
[1] Guta M. 2020. 60% of Americans Worry About Contracting Flu. Small Business News. https://smallbiztrends.com/2020/01/keep-your-business-clean.html
[2] Polansky H., Itzkovitz E. 2013. Gene-Eden-VIR Is Antiviral: Results of a Post-Marketing Study, Pharmacology & Pharmacy (Special Edition: Advances in Anti-Viral Drugs). Abstract. Vol.4 No.6A, 10.4236/pp.2013.46A001.
[3] Polansky H, Javaherian A, Itzkovitz E. 2016. Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus scyclovir, valacyclovir, and famciclovir. Drug Design, Development and Therapy, 10:2713-2722.
[4] Polansky H., 2016. Effective Treatment Against HPV and HSV? https://www.youtube.com/watch?v=VlrR2huFSY4
[5] Polansky H., Itzkovitz E. 2016. Natural Treatment vs. Acyclovir (Zovirax) and other anti-viral drugs. https://www.youtube.com/watch?v=rncF95OBkpA
[6] Polansky H., Javaherian A., Itzkovitz E. 2018. Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin On Oral Herpes. Evidence Based Integr Med. 2018; 23: 2515690X18806269. Published online 2018 Oct 26. doi: 10.1177/2515690X18806269. PMCID: PMC6204621
SOURCE Lilac Corp
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article